The Global Market for Deep Brain Stimulation (DBS) Devices is Projected to Reach US$901 Million by 2020
Unmet Medical
Needs in Neurological Disorders to Drive Demand for Deep Brain Stimulation
Devices, According to a New Report by Global
Industry Analysts, Inc.
GIA announces the release of a comprehensive global
report on the Deep Brain Stimulation Devices. The
global market for Deep Brain Stimulation (DBS) Devices is projected to reach US$901
million by 2020, driven by the high prevalence of neurological &
psychiatric disorders, unmet medical needs, and use of DBS devices in new approved
indications.
Rising prevalence of neurological and psychiatric
disorders is driving demand for novel therapies and treatment. While
pharmacological therapy remains the first-line treatment for these conditions,
their limited effectiveness has prompted the development of alternative
therapeutic options. Deep Brain Stimulation is one such therapy that is
attracting significant interest among researchers, clinicians and patients
alike, largely due to the established efficacy of the treatment, and a slew of
conditions the therapy is indicated for and the potential it holds to gain
approval for several others. DBS is a neurosurgical technique that involves
electrical stimulation of select areas of the brain using an implanted system,
to achieve symptom reduction of diseases. DBS devices comprise an implantable
pulse generator, a lead extension and electrodes. Over the years, DBS showed
remarkable therapeutic benefits in various otherwise treatment-resistant conditions
in both research studies and clinical practice.
Deep Brain Stimulation has revolutionized the
treatment paradigm of certain neurological diseases, such as Parkinson’s
disease, Essential Tremor and Dystonia, offering optimism and hope to several
patients in pursuit of better quality of life. Aging population, unmet medical
needs in the area of neurology, development of novel devices, increase in
treatment indications, robust R&D investments and technology developments,
are key factors driving growth in the market. Also, advances in functional
neuroanatomy, neuroimaging, neurophysiology and neuromodulation are paving way
for new therapeutic possibilities for DBS. Banking on the success of DBS
procedures in the treatment of Parkinson’s disease and essential tremor,
researchers are investigating the efficacy of the procedure in treating a range
of other disorders. Conditions ranging from depression, addiction disorders,
eating disorders, Alzheimer’s, and even obesity have found space in this ambit.
Technological advances are enabling performance and
efficacy improvements of DBS devices. Over the recent years, the market
witnessed the emergence of new pulse generators, replacing conventional
products with limited functionality and agility. Novel features such as
interleaving stimulation or multiprogramming became a possibility with these
devices. More recent advances include the shift towards closed loop
functionality, which generates stimulation based on activation from sensors
thereby addressing the negative outcomes of continuous stimulation typical of traditional
DBS systems. Closed loop stimulation has shown in studies to be more effective
than the conventional open-loop based systems. Another advancement that is
presently under investigation is multidirectional DBS leads.
As stated by the new market research report on Deep
Brain Stimulation Devices, the United States represents the largest market, worldwide.
High incidence and prevalence of neurological conditions, growing awareness over
available therapies, sophisticated and well-established healthcare
infrastructure and significant expertise and experience among surgeons in DBS
are the major factors spurring the dominance of the country in the global
market. Asia-Pacific ranks as the fastest growing market with a CAGR of 13.7%
over the analysis period.
Major players covered in the report include Aleva
Neurotherapeutics SA, Boston Scientific Corp., Deep Brain Innovations, LLC,
Medtronic, plc, and St. Jude Medical, Inc.
The research report titled “Deep
Brain Stimulation Devices: A Global Strategic Business Report” announced by
Global Industry Analysts Inc., provides a
comprehensive review of market trends, issues, drivers, acquisitions and
other strategic industry activities of major companies worldwide. The report
provides market estimates and projections in US$ for all major geographic
markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK,
Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific),
Latin America (Brazil and Rest of Latin America) and Rest of World.
Comments
Post a Comment